Progression on Sotorasib with KRAS+ NSCLC – 2022 Program: Targeted Therapies Forum Non-Small Cell Lung Cancer 1 Min Read0 The landscape of treating KRAS+ NSCLC (Non-Small Cell Lung Cancer) is evolving, and understanding how to approach patient care after…
